Publications en collaboration avec des chercheurs de Universitat de Barcelona (84)

2024

  1. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis

    JHEP Reports, Vol. 6, Núm. 2

  2. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

    Journal of Hepatology, Vol. 81, Núm. 5, pp. 827-836

  3. Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies

    The Lancet Gastroenterology and Hepatology, Vol. 9, Núm. 9, pp. 859-883

  4. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome

    Journal of Hepatology

  5. Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis

    Hepatology, Vol. 79, Núm. 3, pp. 624-635

  6. Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding

    Journal of Hepatology, Vol. 80, Núm. 1, pp. 73-81

  7. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia

  8. Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study

    The Lancet Gastroenterology and Hepatology

  9. Stratified analyses refine association between TLR7 rare variants and severe COVID-19

    Human Genetics and Genomics Advances, Vol. 5, Núm. 4

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode

    Liver International, Vol. 43, Núm. 7, pp. 1548-1557

  3. Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis

    Journal of Hepatology, Vol. 78, Núm. 2, pp. 390-400

  4. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  5. Genome-wide epistasis study highlights genetic interactions influencing severity of COVID-19

    European Journal of Epidemiology, Vol. 38, Núm. 8, pp. 883-889

  6. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

    Gut, Vol. 72, Núm. 4, pp. 749-758

  7. Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis

    Journal of Hepatology, Vol. 78, Núm. 1, pp. 114-122

  8. Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

    Transplantation, Vol. 107, Núm. 6, pp. 1330-1340

  9. Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity

    FASEB Journal, Vol. 37, Núm. 11

  10. Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis

    Hepatology (Baltimore, Md.), Vol. 77, Núm. 6, pp. 2052-2062

  11. Non-invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response

    Liver International, Vol. 43, Núm. 9, pp. 1984-1994